The IN.PACT drug-coated balloon is an over-the-wire angioplasty catheter and drug delivery system for treating people with femoro-popliteal peripheral arterial disease (PAD).

NICE cancelled this evaluation because there was a medical device alert which covered the intended use. This has since been withdrawn.

Status:
Discontinued
Decision:
Prioritised
Process:
MTG
ID number:
336

Project Team

Project lead
N/A

Email enquiries

If you have any queries please email medtech@nice.org.uk

Stakeholders

External assessment group
Kings Health Partners
Manufacturers
Medtronic UK
Manufacturers of related technologies not included in scope
Boston Scientific
 
Terumo
Others
Department for Health and Social Care (DHSC)
 
Healthcare Improvement Scotland (HIS)
 
Johnson & Johnson Medical Ltd
 
Medicines and Healthcare Products Regulatory Agency (MHRA)
 
NHS England (NHSE)
Professional groups
Association of British Healthcare Industries (ABHI)
 
Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
 
British Society of Endovascular Therapy (BSET)
 
British Society of Interventional Radiology (BSIR)
 
Devices for Dignity
 
Medical Technology Group
 
Royal College of Physicians (RCP)
 
The British In Vitro Diagnostics Association (BIVDA)
 
Vascular Society

Timeline

Key events during the development of the guidance:

Date Update
23 May 2024 Discontinued. NICE cancelled this evaluation because there was a medical device alert which covered the intended use. This has since been withdrawn.
19 March 2019 Note added to the project documents
25 October 2018 Note added to the project documents
20 July 2018 Committee meeting: 3
23 May 2018 - 21 June 2018 Draft guidance
23 March 2018 Committee meeting: 2
16 February 2018 Committee meeting: 1
20 September 2017 Scope published
21 August 2017 Stakeholder registration opens

For further information on our processes and methods, please see our CHTE processes and methods manual